Ju Fu Tang Biotech Holdings Co., Ltd. (stock code: 08217) reported that its authorized share capital remained at 500.00 million ordinary shares with a par value of HKD0.16 each, totaling HKD80.00 million as of February 28, 2026. There was no change from the previous month.

The total number of issued shares remained at 301.86 million with no increase or decrease reported. Public float requirements were confirmed to be in compliance at the minimum threshold of 25%. Two share option schemes remained unchanged: one with 10.70 million outstanding options, and another with 9.14 million outstanding options. No new shares were issued during the period under review.